Search results
Results from the WOW.Com Content Network
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
For premium support please call: 800-290-4726 more ways to reach us
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Click here for the latest stock market news and in-depth analysis, including events that move stocks Read the latest financial and business news from Yahoo Finance Download the Yahoo Finance app ...
For premium support please call: 800-290-4726 more ways to reach us
The stock of Stryker (NYSE:SYK, 30-year Financials) gives every indication of being modestly overvalued, according to GuruFocus Value calculation.
Stryker (NYSE:SYK) has had a great run on the share market with its stock up by a significant 14% over the last three...
For premium support please call: 800-290-4726 more ways to reach us